The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Tosoh Corp
DUS:TOS
|
JP |
|
F
|
Friwo AG
XMUN:CEA
|
DE |
|
S
|
SandRidge Energy Inc
F:SA2D
|
US |
|
W
|
Wilh Wilhelmsen Holding ASA
SWB:WML1
|
NO |
|
Digital Brands Group Inc
NASDAQ:DBGI
|
US |
|
D
|
Dongjin Semichem Co Ltd
KOSDAQ:005290
|
KR |
|
I
|
Iovance Biotherapeutics Inc
F:2LB
|
US |
|
Kadant Inc
NYSE:KAI
|
US |
|
N
|
Naspers Ltd
JSE:NPN
|
ZA |
|
Jfrog Ltd
NASDAQ:FROG
|
US |
|
L
|
Live Oak Bancshares Inc
NYSE:LOB
|
US |
|
GS Holdings Ltd
F:6NY
|
SG |
|
C
|
CMOC Group Ltd
XMUN:D7N
|
CN |
|
A
|
Alaska Air Group Inc
F:ALK
|
US |
|
Absa Group Ltd
F:AU6
|
ZA |
|
Propanc Biopharma Inc
NASDAQ:PPCB
|
AU |
|
M
|
My Humble House Hospitality Management Consulting Co Ltd
TWSE:2739
|
TW |
|
L
|
LB Semicon Co Ltd
KOSDAQ:061970
|
KR |
|
F
|
Fujitec Co Ltd
F:FJC
|
JP |
|
Industria de Diseno Textil SA
MAD:ITX
|
ES |
|
C
|
Cleanaway Waste Management Ltd
SWB:TG9
|
AU |
|
F
|
Flutter Entertainment PLC
F:PPB
|
US |
|
W
|
WEX Inc
F:WL9
|
US |
|
J
|
Japan Real Estate Investment Corp
F:JUA
|
JP |
Tosoh Corp (TOS)’s 12-month stock price forecast through October 2027 has a consensus target of €16.21, implying 13% upside. The forecast is based on price targets from 9 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for TOS is 16.21 EUR with a low forecast of 14.15 EUR and a high forecast of 22.37 EUR.
Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 3 years is 6%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 3 years is 6%.
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next -11 years is 4%.
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 8%. The projected CAGR for the next 3 years is 14%.
Over the last 13 years, the compound annual growth rate for Net Income has been 7%. The projected CAGR for the next 3 years is 21%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more